<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PMJ</journal-id>
<journal-id journal-id-type="hwp">sppmj</journal-id>
<journal-id journal-id-type="nlm-ta">Palliat Med</journal-id>
<journal-title>Palliative Medicine</journal-title>
<issn pub-type="ppub">0269-2163</issn>
<issn pub-type="epub">1477-030X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269216312457214</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269216312457214</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: A systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hosie</surname><given-names>Annmarie</given-names></name>
<aff id="aff1-0269216312457214">School of Nursing, The University of Notre Dame, Darlinghurst Campus, Sydney, NSW, Australia; Department of Palliative Care, Calvary Health Care Sydney, Kogarah, NSW, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Davidson</surname><given-names>Patricia M</given-names></name>
<aff id="aff2-0269216312457214">School of Nursing, Midwifery and Health, University of Technology, Sydney, NSW, Australia; ImPaCCT: Improving Palliative Care through Clinical Trials (New South Wales Palliative Care Clinical Trials Group), Sydney, NSW, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Agar</surname><given-names>Meera</given-names></name>
<aff id="aff3-0269216312457214">ImPaCCT: Improving Palliative Care through Clinical Trials (New South Wales Palliative Care Clinical Trials Group), Sydney, NSW, Australia; Palliative and Supportive Services, Flinders University, Adelaide, SA, Australia; South West Sydney Clinical School, University of New South Wales, Liverpool, NSW, Australia; HammondCare, Department of Palliative Care, Braeside Hospital, Sydney, NSW, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Sanderson</surname><given-names>Christine R</given-names></name>
<aff id="aff4-0269216312457214">Department of Palliative Care, Calvary Health Care Sydney, Kogarah, NSW, Australia; ImPaCCT: Improving Palliative Care through Clinical Trials (New South Wales Palliative Care Clinical Trials Group), Sydney, NSW, Australia; Palliative and Supportive Services, Flinders University, Adelaide, SA, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Phillips</surname><given-names>Jane</given-names></name>
<aff id="aff5-0269216312457214">School of Nursing, The University of Notre Dame, Darlinghurst Campus, Sydney, NSW, Australia; ImPaCCT: Improving Palliative Care through Clinical Trials (New South Wales Palliative Care Clinical Trials Group), Sydney, NSW, Australia; St Vincent’s Mater Health, Cunningham Centre for Palliative Care, Sydney, NSW, Australia</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0269216312457214">Annmarie Hosie, School of Nursing, The University of Notre Dame, Darlinghurst Campus, 160 Oxford Street, Sydney, NSW 2010, Australia. Email: <email>annmarie.hosie1@my.nd.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>6</issue>
<fpage>486</fpage>
<lpage>498</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0269216312457214">
<title>Background:</title>
<p>Delirium is a serious neuropsychiatric syndrome frequently experienced by palliative care inpatients. This syndrome is under-recognized by clinicians. While screening increases recognition, it is not a routine practice.</p>
</sec>
<sec id="section2-0269216312457214">
<title>Aim and design:</title>
<p>This systematic review aims to examine methods, quality, and results of delirium prevalence and incidence studies in palliative care inpatient populations and discuss implications for delirium screening.</p>
</sec>
<sec id="section3-0269216312457214">
<title>Data sources:</title>
<p>A systematic search of the literature identified prospective studies reporting on delirium prevalence and/or incidence in inpatient palliative care adult populations from 1980 to 2012. Papers not in English or those reporting the occurrence of symptoms not specifically identified as delirium were excluded.</p>
</sec>
<sec id="section4-0269216312457214">
<title>Results:</title>
<p>Of the eight included studies, the majority (98.9%) involved participants (1079) with advanced cancer. Eight different screening and assessment tools were used. Delirium incidence ranged from 3% to 45%, while delirium prevalence varied, with a range of: 13.3%–42.3% at admission, 26%–62% during admission, and increasing to 58.8%–88% in the weeks or hours preceding death. Studies that used the <italic>Diagnostic and Statistical Manual–Fourth Edition</italic> reported higher prevalence (42%–88%) and incidence (40.2%–45%), while incidence rates were higher in studies that screened participants at least daily (32.8%–45%). Hypoactive delirium was the most prevalent delirium subtype (68%–86% of cases).</p>
</sec>
<sec id="section5-0269216312457214">
<title>Conclusion:</title>
<p>The prevalence and incidence of delirium in palliative care inpatient settings supports the need for screening. However, there is limited consensus on assessment measures or knowledge of implications of delirium screening for inpatients and families. Further research is required to develop standardized methods of delirium screening, assessment, and management that are acceptable to inpatients and families.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Cancer</kwd>
<kwd>delirium</kwd>
<kwd>incidence</kwd>
<kwd>inpatients</kwd>
<kwd>palliative care</kwd>
<kwd>prevalence</kwd>
<kwd>review</kwd>
<kwd>screening</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section6-0269216312457214" sec-type="intro">
<title>Introduction</title>
<p>Delirium is a serious neuropsychiatric syndrome in hospitalized patients, including those within palliative care settings,<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref><xref ref-type="bibr" rid="bibr2-0269216312457214"/>–<xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup> and is associated with increased mortality.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup> Delirium impacts upon the patient’s ability to communicate, their decision-making capacity, functional ability, and quality of life.<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref></sup> Patients who recover from an episode of delirium usually recall the experience<sup><xref ref-type="bibr" rid="bibr6-0269216312457214">6</xref>,<xref ref-type="bibr" rid="bibr7-0269216312457214">7</xref></sup> and report feeling frightened and humiliated.<sup><xref ref-type="bibr" rid="bibr8-0269216312457214">8</xref></sup> In the last days or hours of life, hyperactive delirium symptoms—commonly referred to as “terminal agitation” or “terminal restlessness”—cause distress for family members.<sup><xref ref-type="bibr" rid="bibr9-0269216312457214">9</xref><xref ref-type="bibr" rid="bibr10-0269216312457214"/>–<xref ref-type="bibr" rid="bibr11-0269216312457214">11</xref></sup></p>
<p>Core symptoms for a <italic>Diagnostic and Statistical Manual</italic> (<italic>DSM</italic>), <italic>Fourth Edition</italic> (<italic>DSM</italic>-<italic>IV</italic>) diagnosis of delirium include disturbed consciousness, with reduced ability to focus, sustain, or shift attention; altered cognition or a perceptual disturbance, acute onset and fluctuating symptoms, which can be mild and fleeting or severe and persistent; and evidence of an etiological cause.<sup><xref ref-type="bibr" rid="bibr12-0269216312457214">12</xref></sup> Level of consciousness identifies the three delirium subtypes: hyperactive, hypoactive, or mixed.<sup><xref ref-type="bibr" rid="bibr13-0269216312457214">13</xref></sup> Lethargy, mood changes, and altered sleep–wake cycle can also occur, although are not required to establish a diagnosis.<sup><xref ref-type="bibr" rid="bibr12-0269216312457214">12</xref></sup></p>
<p>Despite numerous interventions for delirium reversal, management and support of palliative care patients with delirium being available, evidence of their effectiveness is evolving and requires further development.<sup><xref ref-type="bibr" rid="bibr14-0269216312457214">14</xref><xref ref-type="bibr" rid="bibr15-0269216312457214"/>–<xref ref-type="bibr" rid="bibr16-0269216312457214">16</xref></sup> Identifying delirium is an important priority as approximately half of all delirium episodes are potentially reversible.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr17-0269216312457214">17</xref></sup> Iatrogenic causes, such as opioids and benzodiazepines, underscore the importance of recognition to modify palliative care interventions.<sup><xref ref-type="bibr" rid="bibr18-0269216312457214">18</xref>,<xref ref-type="bibr" rid="bibr19-0269216312457214">19</xref></sup> Optimal recognition and assessment of delirium is of clinical and ethical concern since sedation is commonly used to manage symptoms of restlessness and agitation in the terminal stage.<sup><xref ref-type="bibr" rid="bibr20-0269216312457214">20</xref>,<xref ref-type="bibr" rid="bibr21-0269216312457214">21</xref></sup> Under-recognition of delirium results in interventions being inconsistently applied in palliative care.<sup><xref ref-type="bibr" rid="bibr22-0269216312457214">22</xref><xref ref-type="bibr" rid="bibr23-0269216312457214"/>–<xref ref-type="bibr" rid="bibr24-0269216312457214">24</xref></sup></p>
<p>Screening improves clinician recognition of delirium,<sup><xref ref-type="bibr" rid="bibr25-0269216312457214">25</xref></sup> yet is not routinely conducted in the inpatient palliative care setting.<sup><xref ref-type="bibr" rid="bibr26-0269216312457214">26</xref></sup> Previous reviews of delirium in palliative care settings have provided comprehensive examinations of the literature including delirium prevalence and assessment methods,<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref>,<xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref>,<xref ref-type="bibr" rid="bibr27-0269216312457214">27</xref></sup> but to date, no reviews have examined in detail the methodological quality of delirium epidemiological studies conducted in palliative care inpatient settings, nor discussed implications of results in conjunction with other evidence required to justify implementation of routine delirium screening.<sup><xref ref-type="bibr" rid="bibr28-0269216312457214">28</xref>,<xref ref-type="bibr" rid="bibr29-0269216312457214">29</xref></sup></p>
</sec>
<sec id="section7-0269216312457214" sec-type="methods">
<title>Method</title>
<sec id="section8-0269216312457214">
<title>Aims and review processes</title>
<p>This systematic review aims to: (1) examine prevalence and incidence of delirium and delirium subtypes in specialist palliative care inpatient settings, at various stages of patients’ admission, (2) describe how delirium cases were identified and established in included studies, and (3) discuss results in relation to implementation of routine delirium screening in specialist palliative care inpatient units.</p>
<p>Although a meta-analysis of data was not undertaken, the Meta-Analysis of Observational Studies in Epide—miology (MOOSE)<sup><xref ref-type="bibr" rid="bibr30-0269216312457214">30</xref></sup> guidelines were followed to facilitate systematic processes in the completion and reporting of the review, where relevant.</p>
</sec>
<sec id="section9-0269216312457214">
<title>Search method</title>
<p>A systematic review was undertaken between 1 December 2011 and 29 February 2012 and was limited to the studies published since 1980, when delirium was first identified within the <italic>DSM, Third Edition</italic> (<italic>DSM-III</italic>),<sup><xref ref-type="bibr" rid="bibr31-0269216312457214">31</xref></sup> up until early 2012. Prospective search questions guided the search strategy using the following search Medical Subject Headings (MeSH) and key words, along with their associated derivatives: “delirium” OR “confusion” OR “terminal agitation” OR “terminal restlessness” OR “psychomotor agitation” OR “cognitive failure” OR “disorientation” AND “palliative care” OR “death” OR “dying” OR “terminal care” OR “hospice care” OR “terminally ill” OR “end of life” AND “prevalence” OR “incidence” OR “epidemiology”. Search engines used were Scopus, CINAHL, and Medline. In addition, the search terms “delirium” AND “prevalence” OR “incidence” OR “epidemiology” were employed in PubMed using the palliative care filter from CareSearch.<sup><xref ref-type="bibr" rid="bibr32-0269216312457214">32</xref></sup> Reference lists of included studies and relevant reviews<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref>,<xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup> were also examined to search for other potentially eligible papers.</p>
</sec>
<sec id="section10-0269216312457214">
<title>Study selection</title>
<p>Criteria for inclusion of papers were prospective assessment studies reporting prevalence, incidence, or rate of occurrence of delirium, conducted within specialist palliative care inpatient settings (defined as palliative care inpatient units or hospices) with adult participants. Studies were excluded if they were not published in English, or reported the rate of occurrence of symptoms or phenomena that were not specifically categorized as delirium, such as “cognitive failure,” “confusion,” or “terminal agitation,” as the interchangeable use of such terms has previously contributed to a lack of clarity in reporting and collating of delirium occurrence in palliative care populations.<sup><xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup> Two authors (A.H. and J.P.) examined the titles and abstracts of all papers to determine if they met the inclusion criteria, one author (A.H.) extracted the data from potentially relevant studies (<italic>n</italic> = 13) and this guided decision making (A.H. and J.P.) about inclusion of studies.</p>
</sec>
<sec id="section11-0269216312457214">
<title>Assessment of methodological quality of included studies</title>
<p>The first author (A.H.) assessed the methodological quality of included studies with reference to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines<sup><xref ref-type="bibr" rid="bibr33-0269216312457214">33</xref></sup> and criteria developed by Boyle<sup><xref ref-type="bibr" rid="bibr34-0269216312457214">34</xref></sup> to evaluate prevalence studies, which were reviewed and confirmed by the other author (J.P.) as follows:</p>
<list id="list1-0269216312457214" list-type="order">
<list-item><p>Sample:<list id="list2-0269216312457214" list-type="alpha-lower">
<list-item><p>Explanation of how the sample size was determined;</p></list-item>
<list-item><p>Study population clearly defined;</p></list-item>
<list-item><p>Two-phase sampling process: delirium screening followed by more comprehensive delirium assessment;</p></list-item>
<list-item><p>Minimum of 80% participation within eligible study population;</p></list-item>
</list></p></list-item>
<list-item><p>Measurement:<list id="list3-0269216312457214" list-type="alpha-lower">
<list-item><p>Standardized data collection methods for all participants of the study;</p></list-item>
<list-item><p>Use of valid delirium-screening and assessment tools AND/OR psychiatric assessment;</p></list-item>
<list-item><p>Reporting of measurement reliability processes, for example, user training in the delirium-screening and assessment tool(s), inter-rater reliability testing, supervision of clinical/research staff conducting study measurements;</p></list-item>
</list></p></list-item>
<list-item><p>Analysis:<list id="list4-0269216312457214" list-type="alpha-lower">
<list-item><p>Confidence intervals included for statistical analysis of frequency estimates.</p></list-item>
</list></p></list-item>
</list>
</sec>
</sec>
<sec id="section12-0269216312457214" sec-type="results">
<title>Results</title>
<p>The initial search generated 815 papers: Scopus (<italic>n</italic> = 758), CINAHL (<italic>n</italic> = 28), Medline (<italic>n</italic> = 8), PubMed via CareSearch (<italic>n</italic> = 21). Within Scopus, adding “AND prospective study,” further refined the search and reduced the number of results within Scopus to 84 papers, resulting in 141 papers across all search engines. Once duplicates were removed, 119 papers published between 1980 and 2011 remained (<xref ref-type="fig" rid="fig1-0269216312457214">Figure 1</xref>). A further 113 papers were removed as they did not report primary research data and/or prospectively measure prevalence or incidence rates of delirium in adult specialist palliative care inpatient units, leaving six papers. Two additional papers<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref></sup> were identified from a hand search of the reference lists of the eligible papers and other reviews.<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref>,<xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup> At the end of the search, eight studies that prospectively measured the prevalence or incidence of delirium in specialist palliative care adult inpatient settings remained (<xref ref-type="table" rid="table1-0269216312457214">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref><xref ref-type="bibr" rid="bibr36-0269216312457214"/>–<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref><xref ref-type="bibr" rid="bibr40-0269216312457214"/>–<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> These included studies which were conducted in the northern hemisphere over a 12-year period (1996–2008).</p>
<fig id="fig1-0269216312457214" position="float">
<label>Figure 1.</label>
<caption>
<p>Flowchart of studies from search to inclusion.</p>
</caption>
<graphic xlink:href="10.1177_0269216312457214-fig1.tif"/>
</fig>
<table-wrap id="table1-0269216312457214" position="float">
<label>Table 1.</label>
<caption><p>Summary of included studies.</p></caption>
<graphic alternate-form-of="table1-0269216312457214" xlink:href="10.1177_0269216312457214-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Publication</th>
<th align="left">Country</th>
<th align="left">Focus</th>
<th align="left">Design/screening and assessment tools/<italic>DSM</italic> Criteria</th>
<th align="left">Participants/participation rate</th>
<th align="left">Delirium prevalence/incidence results</th>
<th align="left">Quality considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td>Minagawa et al.<sup><xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref></sup></td>
<td>Japan</td>
<td>To demonstrate a range of psychiatric disorders in a PC unit.</td>
<td>Prospective assessment by psychiatric investigator using MMSE, psychiatric assessment, and SCID within 1 week of admission.</td>
<td>Terminally ill cancer inpatients (<italic>n</italic> = 93); 59% male; mean age 67.2, <italic>SD</italic> ±11.9 years; participation rate 85%</td>
<td>53.7% met <italic>DSM-III-R</italic> criteria for a psychiatric disorder</td>
<td>Sample size: inpatients recruited over a 13-month period.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td><italic>DSM-III-R</italic></td>
<td/>
<td><italic>Prevalence</italic>: 28% (<italic>n</italic> = 26).
<break/>
<break/>Delirium most common psychiatric disorder</td>
<td>MMSE assesses cognitive function, but is not specific to delirium. SCID does not evaluate organic mental disorders—however, delirium diagnosis determined by psychiatric assessment</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>Confidence intervals not included</td>
</tr>
<tr>
<td>Lawlor et al.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup></td>
<td>USA</td>
<td>To evaluate the occurrence, precipitating factors, and reversibility of delirium in an acute PC unit</td>
<td>Prospective serial assessment in a consecutive cohort. DOCS (by trained ward nurses each 8-h shift), MMSE (by medical investigators on admission and twice weekly), MDAS (by medical investigators for delirious patients).</td>
<td>Advanced cancer patients (<italic>n</italic> = 104 of 113); 51% male; mean age 62 years, <italic>SD</italic> ± 1.9 years; participation rate 100%</td>
<td><italic>Prevalence on admission</italic>: 42% (<italic>n</italic> = 44)
<break/>
<break/><italic>Incidence</italic>: 45% of patients who were delirium-free on admission (<italic>n</italic> = 27/60)
<break/><italic>Prevalence hours before death</italic>: 88% (<italic>n</italic> = 46/52)</td>
<td>Sample size: inpatients recruited over a 9.5-month period
<break/>
<break/>DOCS had no reliability or validity testing
<break/>
<break/>MMSE assesses cognitive function, but is not specific to delirium</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Semi-structured interview by medical investigators to operationalize <italic>DSM-IV</italic>.</td>
<td/>
<td/>
<td>Researcher training and moderate-to-high inter-rater reliability in MDAS use was reported in a separate paper38</td>
</tr>
<tr>
<td>Gagnon et al.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup></td>
<td>Canada</td>
<td>To determine delirium frequency and outcome in hospice inpatients</td>
<td>Prospective cohort study. CRS (by trained ward nurses 8th-hourly), BOMC to assess orientation, CAM (by two research nurses to diagnose delirium). Training and supervision of research nurses by psychiatric investigator</td>
<td>Terminal cancer inpatients (<italic>n</italic> = 89) with a life expectancy &lt;2 months; 48% male; mean (median) age 66 years (68 years); participation rate 95%</td>
<td><italic>Prevalence</italic>: On admission, 20.2% patients (<italic>n</italic> = 18) had delirium symptoms, diagnosis confirmed in 13.3%<break/><italic>Incidence</italic>: 52.1% of 71 patients delirium-free at admission developed delirium symptoms, diagnosis confirmed in 32.8%</td>
<td>Sample size: inpatients recruited over a 4-month period<break/>CRS requires further validation</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td><italic>DSM-III-R</italic></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Sarhill et al.<sup><xref ref-type="bibr" rid="bibr40-0269216312457214">40</xref></sup></td>
<td>USA</td>
<td>(a) Evaluate the use of the BCS and (b) determine prevalence, cause, precipitants, and treatment of delirium in an acute PC medicine unit</td>
<td>Prospective assessment by medical officer on admission using the BCS (delirium = score of ≥2)<break/>DSM criteria for delirium not used</td>
<td>Consecutive patients with advanced cancer (<italic>n</italic> = 41/50); 44% male; median age 65 years; participation rate 82%</td>
<td><italic>Prevalence</italic>: 31.7% (<italic>n</italic> = 13) on admission</td>
<td>Sample size: inpatients recruited over a 2-month period<break/>Multiphase sampling not used—delirium screening only<break/>BCS requires further psychometric testing<break/>Not specified who applied BCS (medical clinician, researcher, or investigator)<break/>Confidence intervals not included.</td>
</tr>
<tr>
<td>Durkin et al.<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></td>
<td>UK</td>
<td>To clinically assess the prevalence of psychiatric disorder occurring in a PC unit and ascertain whether disorder had been detected and treated prior to admission</td>
<td>Prospective assessment of patients on admission and twice weekly by principal psychiatric investigator.<break/>Presence or absence of a psychiatric diagnosis was determined according to the ICD-10 Diagnostic Criteria for Research</td>
<td>Inpatients with diagnosis of AIDS or advanced cancer (<italic>n</italic> = 224); 52% male; mean age 66 years, <italic>SD</italic>±14.2, range 22–90 years; participation rate 100%</td>
<td>62% (<italic>n</italic> = 139) met ICD-10 diagnostic criteria for psychiatric disorder<break/><italic>Prevalence</italic>: 19% (<italic>n</italic> = 43)Incidence: 3% patients (<italic>n</italic> = 5/181) delirium-free on admission developed delirium</td>
<td>Sample size: inpatients recruited over a 6-month period<break/>Multiphase sampling did not occur—no delirium-screening tool used<break/>Confidence intervals not included</td>
</tr>
<tr>
<td>Lam et al.<sup><xref ref-type="bibr" rid="bibr42-0269216312457214">42</xref></sup></td>
<td>Hong Kong</td>
<td>To estimate the incidence and prevalence of delirium in a PC unit and evaluate psychomotor type, etiologies, reversibility and other characteristics</td>
<td>Prospective daily assessment of consecutive admissions using structured evaluation, MMSE—Cantonese version, KPS.<break/>Patients assessed as delirious had further assessment by medical investigator within the same day to confirm delirium diagnosis. Experienced and trained nurse administered<break/>MDAS within 24 h of delirium diagnosis<break/>DSM-IV</td>
<td>Advanced cancer patients (<italic>n</italic> = 82/102); 46% male; mean age 68 years, <italic>SD</italic>±12.5; participation rate 80%.</td>
<td><italic>Prevalence</italic>: 58.8% (<italic>n</italic> = 30/51) of patients who died had delirium on average 12.4 days before death<break/><italic>Incidence</italic>: 40.2% (<italic>n</italic> = 33)Subtypes: 70% hypoactive<break/><italic>Severity</italic>: 53.3% mild severity, 23.3% moderate, 20% severe</td>
<td>Sample size: inpatients recruited over a 4-month period<break/>MMSE assesses cognitive function, but is not specific to delirium<break/>Training and supervision of clinical staff conducting daily delirium monitoring was not reported</td>
</tr>
<tr>
<td>Spiller and Keen<sup><xref ref-type="bibr" rid="bibr43-0269216312457214">43</xref></sup></td>
<td>Scotland</td>
<td>To assess the prevalence of hypoactive delirium in specialist PC settings</td>
<td>Study 1: Prospective assessments at admission and 7 days later by study investigator using MMSE, CAM, MDAS, FSS, HADS</td>
<td>Study 1: Hospice inpatients (<italic>n</italic> = 100); 49% male; mean age 68.7 years, <italic>SD</italic> ± 15 years; 99/100 advanced malignancy; participation rate 88% at admission, 73% at 7 days</td>
<td>Study 1: <italic>Prevalence</italic>: 29% (<italic>n</italic> = 29) at admission—86% hypoactive, 14% mixed 26% (<italic>n</italic> = 19/73) had delirium 7 days later—68% hypoactive, 21% hyperactive, 11% mixed</td>
<td>Determination of sample size of 100 for Study 1 was not explained. MMSE assesses cognitive function but is not specific to delirium.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Study 2: 48-h point prevalence study in 8 specialist PC units using MMSE, CAM, MDAS (administered by trained clinical staff, discipline/s not specified)DSM-III-R</td>
<td>Study 2: Inpatients (<italic>n</italic> = 109) of 8 PC units (6 hospices, 1 hospice ward within a general hospital, 1 PC service within a general hospital); gender not specified; mean age 68.7 years, diagnoses not specified; participation rate 87%</td>
<td><italic>Incidence</italic>: 7% (<italic>n</italic> = 5 /73) within 7 days of admission.<break/>Study 2: <italic>Point prevalence</italic>: 29.4% (<italic>n</italic> = 32) (range 14%–35%). 78% hypoactive, 6% hyperactive, 16% mixed</td>
<td>No reporting of researcher training in use of CAM, MDAS in Study 1<break/>Diagnoses of study population not reported in Part 2<break/>Confidence intervals included in Part 1, but not Part 2</td>
</tr>
<tr>
<td>Fang et al.<sup><xref ref-type="bibr" rid="bibr44-0269216312457214">44</xref></sup></td>
<td>Taiwan</td>
<td>To determine the prevalence, detection, and treatment of delirium in an acute PC/hospice unit</td>
<td>Survey and chart review, screening by trained research nurse using the DRS-CV at admission and second daily, followed by psychiatrist review for +ve DRS-CV to verify diagnosis and determine delirium subtypeDSM-IV</td>
<td>Terminal cancer inpatients (<italic>n</italic> = 228/457); 51% male; mean age 64.57 <italic>SD</italic> ± 14.88; participation rate 49.9%</td>
<td><italic>Prevalence</italic>: 46.9%.<break/><italic>Subtypes</italic>: 68.2% hypoactive, 21.5% hyperactive, 10.3% mixed</td>
<td>Sample size: inpatients recruited over a 6-month period<break/>Largest sample within included studies, but participation rate &lt;80%. 51% of nonparticipants were too ill to consent, indicating selection bias</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269216312457214">
<p>BOMC: Blessed Orientation Memory Concentration; BCS: Bedside Confusion Scale; CAM: Confusion Assessment Method; CRS: Confusion Rating Scale; DOCS: Delirium Observational Checklist Scale; DRS-CV: Delirium Rating Scale–Chinese Version; DS: Delirium Scale; <italic>DSM: Diagnostic and Statistical Manual; DSM-III-R: DSM, Third Edition, Text Revision</italic>; FSS: Fatigue Severity Scale; HADS: Hospital Anxiety and Depression Scale; KPS: Karnofsky Performance Scale; MDAS: Memorial Delirium Assessment Scale; MMSE: Mini-Mental State Examination; PC: palliative care; SCID: Structured Clinical Interview for <italic>DSM-III-R</italic>; ICD-10: International Statistical Classification of Diseases and Related Health problems.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section13-0269216312457214">
<title>Setting, diagnosis, and demographics</title>
<p>The included studies were undertaken in patient settings described variously as hospices (<italic>n</italic> = 2),<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> palliative care units (<italic>n</italic> = 3),<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref><xref ref-type="bibr" rid="bibr36-0269216312457214"/>–<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref></sup> acute palliative care units (<italic>n</italic> = 2),<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr40-0269216312457214">40</xref></sup> and a combined acute palliative care unit/hospice (<italic>n</italic> = 1).<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup> Where described, the purpose of the settings included symptom control, respite, rehabilitation, and/or terminal care for palliative care patients. The majority (98.9%) of all participants (<italic>n</italic> = 1079) across these studies had advanced cancer, with some diagnoses not specified in one study.<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Two studies included participants with other life limiting diseases: (a) immunodeficiency disorders (<italic>n</italic> = 11)<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref></sup> and (b) end-stage cardiac failure and cerebrovascular disease (<italic>n</italic> = 1).<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></p>
<p>Across the studies, there was equal representation of males and females, with a mean age of 66.24 years (range 62–68.7 years). Participation rates varied (<xref ref-type="table" rid="table1-0269216312457214">Table 1</xref>).</p>
</sec>
<sec id="section14-0269216312457214">
<title>Study characteristics, design, quality, and focus</title>
<p>There was variability in study characteristics, design, quality, and foci, as well as participant numbers (X 120, range 41<sup><xref ref-type="bibr" rid="bibr40-0269216312457214">40</xref></sup>–228 people<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup>). No studies reported statistical explanations for determination of sample size, with this appearing to be largely determined by number of patient admissions within study periods. Delirium occurrence was measured at different frequencies and points of time during the admission, while five studies measured both delirium prevalence and incidence.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></p>
<p>Different criteria were used to define the terminal stage, with the last weeks of life considered the “pre-terminal and terminal” stage of cancer in two studies.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> “Terminally ill” or “terminal” cancer patients were elsewhere considered to be within the last 6 months of life.<sup><xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref></sup> Only one study included the data specifically collected in the 6 hours immediately prior to death, defined as “terminal delirium.”<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup></p>
<p>Methodological quality of studies varied considerably and no study met all quality criteria (<xref ref-type="table" rid="table1-0269216312457214">Table 1</xref>).</p>
</sec>
<sec id="section15-0269216312457214">
<title>Definitions of delirium and diagnostic criteria used</title>
<p>Diagnostic criteria adopted by many of the studies, conducted at different time points, reflect the evolution of the <italic>DSM</italic> diagnostic criteria for delirium. The majority (<italic>n</italic> = 6) of studies applied <italic>DSM</italic> criteria to diagnose delirium, with two using the research gold standard of psychiatrist assessment to confirm delirium against the <italic>DSM</italic> version current at the time.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref></sup> In another four studies, diagnosis of delirium was based on the presence of the then-current <italic>DSM</italic> criteria, although not confirmed by psychiatric assessment.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> The remaining two studies used an alternative criteria to establish a delirium diagnosis with one<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref></sup> using the International Statistical Classification of Diseases and Related Health problems (ICD-10) Diagnostic Criteria for Research,<sup><xref ref-type="bibr" rid="bibr42-0269216312457214">42</xref></sup> which requires a greater range of symptoms to be present to establish a delirium diagnosis.</p>
</sec>
<sec id="section16-0269216312457214">
<title>Screening and assessment tools</title>
<p>Eight different tools were used across the studies to assess cognition, screen for, or establish delirium (<xref ref-type="table" rid="table1-0269216312457214">Table 1</xref>). Of the six delirium-specific screening or assessment tools, all varied in their validity, purpose (screening, diagnosis, and severity), intended rater (psychiatrically vs nonpsychiatrically trained), ratings procedures (observation vs interview), number of items, and extent to which they correlate with different versions of <italic>DSM</italic> criteria for delirium.<sup><xref ref-type="bibr" rid="bibr43-0269216312457214">43</xref>,<xref ref-type="bibr" rid="bibr44-0269216312457214">44</xref></sup></p>
<p>Three delirium or “confusion” screening tools included the Confusion Rating Scale (CRS) used by ward nurses<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr45-0269216312457214">45</xref></sup>; the Bedside Confusion Scale (BCS) used by medical investigators<sup><xref ref-type="bibr" rid="bibr40-0269216312457214">40</xref>,<xref ref-type="bibr" rid="bibr46-0269216312457214">46</xref></sup>; and the Delirium Observational Checklist Scale (DOCS), an instrument developed by study investigators for ward nurse’s use.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup> Although the BCS was previously validated in the palliative care setting, it requires further investigation of its psychometric properties.<sup><xref ref-type="bibr" rid="bibr43-0269216312457214">43</xref></sup> The CRS requires further validation, and the DOCS is not a validated delirium-screening tool.<sup><xref ref-type="bibr" rid="bibr43-0269216312457214">43</xref></sup></p>
<p>Two cognition assessment tools, used to either screen for delirium or to assist in delirium assessment, were the Mini-Mental State Examination (MMSE)<sup><xref ref-type="bibr" rid="bibr47-0269216312457214">47</xref></sup> used by psychiatric and medical investigators<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> or clinical staff<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> and the Blessed Orientation Memory Concentration (BOMC) test used by research nurses.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr48-0269216312457214">48</xref></sup></p>
<p>Three delirium assessment tools were the Confusion Assessment Method (CAM)<sup><xref ref-type="bibr" rid="bibr49-0269216312457214">49</xref></sup> used by research nurses<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> or medical investigators and trained clinical staff<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup>; the Memorial Delirium Assessment Scale (MDAS)<sup><xref ref-type="bibr" rid="bibr38-0269216312457214">38</xref>,<xref ref-type="bibr" rid="bibr50-0269216312457214">50</xref></sup> used by medical investigators,<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> trained clinical staff,<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> or a research nurse<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup>; and the Delirium Rating Scale–Chinese Version (DRS-CV)<sup><xref ref-type="bibr" rid="bibr51-0269216312457214">51</xref></sup> used by a research nurse.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup> Only the MDAS<sup><xref ref-type="bibr" rid="bibr38-0269216312457214">38</xref>,<xref ref-type="bibr" rid="bibr50-0269216312457214">50</xref></sup> and the Delirium Rating Scale (DRS)<sup><xref ref-type="bibr" rid="bibr46-0269216312457214">46</xref>,<xref ref-type="bibr" rid="bibr52-0269216312457214">52</xref>,<xref ref-type="bibr" rid="bibr53-0269216312457214">53</xref></sup> were validated in palliative care or advanced cancer populations prior to use in the studies under examination, with the MDAS undergoing further simultaneous validation.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr38-0269216312457214">38</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> The CAM<sup><xref ref-type="bibr" rid="bibr49-0269216312457214">49</xref></sup> was validated in other clinical settings and languages,<sup><xref ref-type="bibr" rid="bibr43-0269216312457214">43</xref></sup> and subsequently validated in the palliative care setting.<sup><xref ref-type="bibr" rid="bibr54-0269216312457214">54</xref></sup></p>
<p>No studies reported perspectives of patients or families of the acceptability of delirium-screening and assessment processes.</p>
</sec>
<sec id="section17-0269216312457214">
<title>Delirium prevalence and incidence rates</title>
<p>The prevalence and incidence rates reported in the included studies are represented graphically in <xref ref-type="fig" rid="fig2-0269216312457214">Figure 2</xref>.</p>
<fig id="fig2-0269216312457214" position="float">
<label>Figure 2.</label>
<caption>
<p>Graphical representation of delirium prevalence and incidence rates in specialist palliative care inpatient units from results of included studies.</p>
</caption>
<graphic xlink:href="10.1177_0269216312457214-fig2.tif"/>
</fig>
<sec id="section18-0269216312457214">
<title>On admission</title>
<p>Five studies measured delirium prevalence at admission, ranging from 13.3% to 42.3% of patients.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref><xref ref-type="bibr" rid="bibr40-0269216312457214"/>–<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Of 104 advanced cancer admissions to an acute palliative care unit, delirium was present at admission in 42.3% of patients.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup> A later study, consecutively measured delirium frequency in hospice inpatients (<italic>n</italic> = 89) and 13.3% were confirmed to have delirium.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> In another, 19% of patients (<italic>n</italic> = 224) admitted to a palliative care unit had delirium.<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref></sup> A third (32%) of participants (<italic>n</italic> = 41) were classified as delirious according to presence of inattention and altered level of alertness in one acute palliative care unit,<sup><xref ref-type="bibr" rid="bibr40-0269216312457214">40</xref></sup> while 29% of participating patients (<italic>n</italic> = 100) admitted to a Scottish hospice had delirium.<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></p>
</sec>
<sec id="section19-0269216312457214">
<title>During admission</title>
<p>Delirium prevalence across the whole cohort of palliative care inpatients during each study period ranged from 26% to 62%.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> One study measuring psychiatric morbidity at one point during the week after admission to a palliative care unit found that delirium was the most prevalent psychiatric disorder, occurring in 28% of all participants and representing 52% of all psychiatric diagnoses.<sup><xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref></sup> Another study, using delirium screening during each 8-h shift, identified that 62% of participants developed delirium at some point during hospice admission.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> One study reassessed hospice patients (<italic>n</italic> = 73) 7 days after admission and found that 26% had delirium, while across 8 hospices or inpatient palliative care services, 29.4% of patients had a delirium diagnosis during a 48-h period of assessment.<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Recently, 46.9% of palliative care inpatients (<italic>n</italic> = 228) screened second daily were found to have delirium.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup></p>
<p>Three studies examined occurrence of delirium subtypes and all reported that the majority of delirious patients experienced hypoactive delirium (68%–86%).<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></p>
<p>Five studies measured delirium incidence after admission and reported rates of between 3% and 45%.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Delirium developed during admission in 45% of patients (<italic>n</italic> = 60).<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup> In a later study involving 71 participants, 32.8% had confirmed delirium.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> These two studies included screening by ward nurses each 8-h shift.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> A study using daily screening reported, of admitted patients, 40.2% (<italic>n</italic> = 82) developed delirium (<italic>n</italic> = 33/82), the majority (70%) having hypoactive delirium of mild severity (53.3%).<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> In contrast, one study reported development of five new cases in 73 patients within a 7-day period, an incidence of 7%,<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> while another, using twice weekly assessment and the ICD-10 diagnostic criteria, reported an incidence of only 3%: during the 6-month study period only 5 of 181 patients delirium-free on admission subsequently developed delirium.<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref></sup></p>
</sec>
<sec id="section20-0269216312457214">
<title>Preceding death</title>
<p>Two studies measured prevalence of delirium in the weeks or hours before death, reporting rates of 58.8%–88%.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> The most recent study reported 58% delirium prevalence in patients (<italic>n</italic> = 51) who died during admission.<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> Only one study explicitly measured and reported occurrence of delirium in the last 6 h of life in an acute palliative care unit and found that the majority (88%) had delirium.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup></p>
</sec>
</sec>
<sec id="section21-0269216312457214">
<title>Variation in delirium prevalence and incidence according to study methods and settings</title>
<p>Studies that used <italic>DSM-IV</italic> criteria reported higher delirium prevalence (42%–88%)<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> and incidence (40.2%–45%)<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup>; compared to studies using earlier versions of <italic>DSM</italic> criteria and ICD-10 (prevalence 13.3%–29.4%<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> and incidence 3%–32.8%).<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Studies screening participants daily or more often reported higher delirium incidence (32.8%–45%)<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> than studies that screened or assessed delirium participants less frequently (3%–7%).<sup><xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> Delirium prevalence on admission varied slightly across settings: palliative care unit (19%), hospice (13.3%–29%), and acute palliative care units (31.7%–42%).</p>
</sec>
<sec id="section22-0269216312457214">
<title>Role of clinicians in the identification and diagnosis of delirium</title>
<p>In four studies, clinicians were actively involved in delirium screening and assessment study processes.<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> In two, ward nurses screened for delirium, using the DOCS<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref></sup> or the CRS<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> and received training in use of tools and features of delirium.<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> In another, an experienced and trained nurse assessed delirious patients using the MDAS to measure delirium severity.<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> In the study involving 8 separate Scottish hospices and palliative care services, clinicians received training prior to using the CAM and MDAS to identify and assess delirium over a 48-h period.<sup><xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup></p>
<p>Research nurses were also involved in delirium screening and assessment. The DRS-CV was used to screen inpatients for delirium,<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup> delirium diagnosis was established by nurses in another using the CAM in consultation with the psychiatric investigator if there was uncertainty about the diagnosis,<sup><xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> and delirium severity was measured by nurses using the MDAS 24 h after delirium diagnosis by a physician.<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup></p>
</sec>
</sec>
<sec id="section23-0269216312457214" sec-type="discussion">
<title>Discussion</title>
<p>There were some similarities across studies, with most adopting a two-phase sampling method—delirium screening followed by assessment—and involving patients of a similar age and primary cancer diagnosis. However, there was a varying methodological quality across these studies, with heterogeneity of diagnostic criteria, sample sizes, frequency of assessment, and measurement tools adopted. Despite these differences and the variation in reported delirium occurrence, categorizing delirium prevalence at different points along the palliative care inpatient trajectory indicates that prevalence is lower at admission (range 13.3%–42.3%),<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr36-0269216312457214">36</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref><xref ref-type="bibr" rid="bibr40-0269216312457214"/>–<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> increases during admission (range 26%–62%),<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr37-0269216312457214">37</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref></sup> with the risk of developing delirium escalating as death nears (range 58.8%–88%).<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> This review has confirmed that palliative care inpatient populations have delirium incidence and prevalence equal to or greater than other known high-risk populations, such as older people admitted to hospital,<sup><xref ref-type="bibr" rid="bibr55-0269216312457214">55</xref></sup> Intensive Care Units,<sup><xref ref-type="bibr" rid="bibr56-0269216312457214">56</xref><xref ref-type="bibr" rid="bibr57-0269216312457214"/>–<xref ref-type="bibr" rid="bibr58-0269216312457214">58</xref></sup> post hip surgery,<sup><xref ref-type="bibr" rid="bibr59-0269216312457214">59</xref>,<xref ref-type="bibr" rid="bibr60-0269216312457214">60</xref></sup> and long-term care.<sup><xref ref-type="bibr" rid="bibr61-0269216312457214">61</xref></sup></p>
<p>The review adds to the emerging evidence that hypoactive delirium is the most prevalent subtype in palliative care populations.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr41-0269216312457214">41</xref>,<xref ref-type="bibr" rid="bibr62-0269216312457214">62</xref></sup> Hypoactive delirium may appear less severe than other subtypes<sup><xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref></sup> and cause less difficulties in ward management,<sup><xref ref-type="bibr" rid="bibr63-0269216312457214">63</xref></sup> but is associated with increased mortality.<sup><xref ref-type="bibr" rid="bibr5-0269216312457214">5</xref></sup> It also has a significant impact on patients and families since cognitive changes occur as often as in the hyperactive and mixed subtypes.<sup><xref ref-type="bibr" rid="bibr62-0269216312457214">62</xref>,<xref ref-type="bibr" rid="bibr64-0269216312457214">64</xref></sup></p>
<p>Clinicians were involved in patient screening and assessment in half the studies, highlighting potential for routine delirium screening outside a research context, and feasibility of increasing delirium recognition capabilities by nonpsychiatric clinicians through training and access to validated delirium-screening and assessment tools.<sup><xref ref-type="bibr" rid="bibr38-0269216312457214">38</xref>,<xref ref-type="bibr" rid="bibr50-0269216312457214">50</xref>,<xref ref-type="bibr" rid="bibr54-0269216312457214">54</xref></sup> Delirium screening by nurses in a hospice setting has been demonstrated to be feasible and effective.<sup><xref ref-type="bibr" rid="bibr14-0269216312457214">14</xref>,<xref ref-type="bibr" rid="bibr25-0269216312457214">25</xref></sup> However, the challenges of screening for delirium in palliative care populations was also demonstrated by the small proportion of included studies measuring delirium occurrence specifically in cohorts of patients who were dying, and proportion of patients and/or families who declined to participate in the delirium assessment process, indicating delirium assessment is not always acceptable to them. Additionally, many patients were too unwell to provide consent or were excluded because they were dying, comatose, or could not speak. Similarly, a recent study<sup><xref ref-type="bibr" rid="bibr14-0269216312457214">14</xref></sup> reported a low rate of CAM completion by hospice nurses (39%), highlighting the difficulty of conducting this delirium assessment in the last days of life and need for validated low-burden delirium assessment tools at this time.</p>
<p>Applying the <italic>DSM-IV</italic> criteria appears to lead to increased case finding, which has been previously reported<sup><xref ref-type="bibr" rid="bibr65-0269216312457214">65</xref></sup>; and interestingly, variability in delirium prevalence and incidence noted in this review reflects results of similar reviews that included studies using less-specific delirium definitions.<sup><xref ref-type="bibr" rid="bibr1-0269216312457214">1</xref>,<xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup></p>
<sec id="section24-0269216312457214">
<title>Implications for clinical practice and future research</title>
<p>As daily screening increases detection of incident delirium,<sup><xref ref-type="bibr" rid="bibr4-0269216312457214">4</xref>,<xref ref-type="bibr" rid="bibr35-0269216312457214">35</xref>,<xref ref-type="bibr" rid="bibr39-0269216312457214">39</xref></sup> the question remains: should routine screening be implemented in palliative care inpatient settings? Clinical practice guidelines for other high-risk patient populations recommend screening to improve early recognition of delirium,<sup><xref ref-type="bibr" rid="bibr55-0269216312457214">55</xref>,<xref ref-type="bibr" rid="bibr66-0269216312457214">66</xref>,<xref ref-type="bibr" rid="bibr67-0269216312457214">67</xref></sup> although the extent to which this has been routinely adopted is unknown. However, a number of other key questions require investigation to justify routine screening<sup><xref ref-type="bibr" rid="bibr28-0269216312457214">28</xref>,<xref ref-type="bibr" rid="bibr29-0269216312457214">29</xref></sup> including: Is screening acceptable to patients and family and cause minimal harm? Is it cost-effective? Does early recognition and treatment of delirium improve mortality and morbidity? And, what are the adverse effects of delirium treatment?<sup><xref ref-type="bibr" rid="bibr28-0269216312457214">28</xref>,<xref ref-type="bibr" rid="bibr29-0269216312457214">29</xref></sup></p>
<p>Further research in delirium prevention interventions in palliative care,<sup><xref ref-type="bibr" rid="bibr14-0269216312457214">14</xref></sup> and high-level evidence of the efficacy and safety of pharmacological interventions, such as antipsychotics, benzodiazepines, and methylphenidate, is needed.<sup><xref ref-type="bibr" rid="bibr16-0269216312457214">16</xref>,<xref ref-type="bibr" rid="bibr68-0269216312457214">68</xref>,<xref ref-type="bibr" rid="bibr69-0269216312457214">69</xref></sup> Measuring impact of interventions on delirium incidence, severity, and patient mortality should continue to be a focus of research, but as improvements in morbidity and mortality are likely to be minimal in this population and the focus of care is a relief of distress and suffering, patients’ and families’ subjective experiences (such as perceptions of care, distress, dignity, and quality of life) related to delirium screening, recognition, and treatment are especially important outcomes to be determined.<sup><xref ref-type="bibr" rid="bibr70-0269216312457214">70</xref></sup> Development of acceptable, observational delirium screening and assessment strategies for palliative care patients who are very ill, dying, or unable to communicate is also required.<sup><xref ref-type="bibr" rid="bibr8-0269216312457214">8</xref>,<xref ref-type="bibr" rid="bibr28-0269216312457214">28</xref>,<xref ref-type="bibr" rid="bibr29-0269216312457214">29</xref></sup></p>
<p>This review has highlighted the lack of consensus regarding selection of delirium screening and assessment tools in palliative care research, and this is likely to be reflected in clinical practice. Establishing the acceptability of various delirium-screening and assessment tools by patients and families would inform the sector about which are the most appropriate to use in this population, particularly in the dying stage. Establishing consensus would facilitate delirium benchmarking, quality improvement,<sup><xref ref-type="bibr" rid="bibr71-0269216312457214">71</xref>,<xref ref-type="bibr" rid="bibr72-0269216312457214">72</xref></sup> and consistency of research methodology. To further improve methodological and reporting quality of future delirium epidemiological research in palliative care populations, consideration of recently developed guidelines for observational studies in epidemiology is recommended.<sup><xref ref-type="bibr" rid="bibr33-0269216312457214">33</xref>,<xref ref-type="bibr" rid="bibr73-0269216312457214">73</xref></sup></p>
<p>Health-economic analysis will also be an important inclusion in future delirium research, when high health-care costs associated with delirium occurrence in elderly inpatient populations is considered.<sup><xref ref-type="bibr" rid="bibr74-0269216312457214">74</xref>,<xref ref-type="bibr" rid="bibr75-0269216312457214">75</xref></sup></p>
</sec>
<sec id="section25-0269216312457214">
<title>Study limitations and strengths</title>
<p>Limitations of this review include exclusion of papers not published in English, potentially contributing to selection bias and the absence of multiple independent raters in the extraction of data to assess eligibility and quality of included studies. There are limitations related to generalizability of this review due to the focus on advanced cancer diagnoses within study populations.<sup><xref ref-type="bibr" rid="bibr70-0269216312457214">70</xref></sup> As the brief of palliative care shifts to nonmalignant conditions and settings where end-of-life care is routinely provided, for example, elderly medical inpatient settings or nursing homes, it is important to consider implications of this changing population.<sup><xref ref-type="bibr" rid="bibr76-0269216312457214">76</xref><xref ref-type="bibr" rid="bibr77-0269216312457214"/>–<xref ref-type="bibr" rid="bibr78-0269216312457214">78</xref></sup> In addition, although results suggest increasing delirium prevalence as death nears, this was not confirmed within this review due to variable reporting of participants’ functional status and illness staging, and variation in operational definitions of “terminal.” This barrier has been previously noted with a recommendation that all future delirium occurrence studies incorporate a patient cohort classification system based on estimated prognosis.<sup><xref ref-type="bibr" rid="bibr3-0269216312457214">3</xref></sup></p>
<p>The strengths of this review include use of a systematic approach, with application of accepted guidelines and a structured approach to the assessment of quality of included studies.<sup><xref ref-type="bibr" rid="bibr30-0269216312457214">30</xref>,<xref ref-type="bibr" rid="bibr33-0269216312457214">33</xref></sup></p>
</sec>
</sec>
<sec id="section26-0269216312457214" sec-type="conclusions">
<title>Conclusion</title>
<p>This review has examined methods, quality, and results of studies prospectively measuring delirium occurrence in specialist palliative care inpatient settings and identified additional evidence needed to justify routine delirium screening in these settings. While the moderate to high rate of delirium occurrence in palliative care inpatient units supports the need for delirium screening, there is also a need to develop consensus and quality of methods for measuring delirium occurrence, and we require evidence regarding impact, acceptability, potential harms and cost-effectiveness of delirium screening and assessment, and outcomes of screening and treatments on morbidity, mortality, and patients’ and families’ subjective experiences.</p>
</sec>
</body>
<back>
<ack><p>The authors would like to acknowledge the contribution of Ms Caroline Yeh, Librarian, St Vincent’s Hospital, Darlinghurst, Sydney, Australia in the development of the literature search strategy.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>An Australian Postgraduate Award from the Commonwealth Government of Australia supported A.H. in this work.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0269216312457214">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Agar</surname><given-names>M</given-names></name>
<name><surname>Mason</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Delirium issues in palliative care settings</article-title>. <source>J Psychosom Res</source> <year>2008</year>; <volume>65</volume>(<issue>3</issue>): <fpage>289</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr2-0269216312457214">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friedlander</surname><given-names>MM</given-names></name>
<name><surname>Yanina</surname><given-names>B</given-names></name>
<name><surname>Breitbart</surname><given-names>WS</given-names></name>
</person-group>. <article-title>Delirium in palliative care</article-title>. <source>Oncology</source> <year>2004</year>; <volume>18</volume>(<issue>12</issue>): <fpage>1541</fpage>–<lpage>1550</lpage>.</citation>
</ref>
<ref id="bibr3-0269216312457214">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hjermstad</surname><given-names>MJ</given-names></name>
<name><surname>Loge</surname><given-names>JH</given-names></name>
<name><surname>Kaasa</surname><given-names>S</given-names></name>
</person-group>. <article-title>Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research</article-title>. <source>Palliat Med</source> <year>2004</year>; <volume>18</volume>(<issue>6</issue>): <fpage>494</fpage>–<lpage>506</lpage>.</citation>
</ref>
<ref id="bibr4-0269216312457214">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lawlor</surname><given-names>PG</given-names></name>
<name><surname>Gagnon</surname><given-names>B</given-names></name>
<name><surname>Mancini</surname><given-names>IL</given-names></name><etal/>
</person-group>. <article-title>Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study</article-title>. <source>Arch Intern Med</source> <year>2000</year>; <volume>160</volume>(<issue>6</issue>): <fpage>786</fpage>–<lpage>794</lpage>.</citation>
</ref>
<ref id="bibr5-0269216312457214">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fang</surname><given-names>CK</given-names></name>
<name><surname>Chen</surname><given-names>HW</given-names></name>
<name><surname>Liu</surname><given-names>SI</given-names></name><etal/>
</person-group>. <article-title>Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey</article-title>. <source>Jpn J Clin Oncol</source> <year>2008</year>; <volume>38</volume>(<issue>1</issue>): <fpage>56</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr6-0269216312457214">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Breitbart</surname><given-names>W</given-names></name>
<name><surname>Gibson</surname><given-names>C</given-names></name>
<name><surname>Tremblay</surname><given-names>A</given-names></name>
</person-group>. <article-title>The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses</article-title>. <source>Psychosomatics</source> <year>2002</year>; <volume>43</volume>(<issue>3</issue>): <fpage>183</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr7-0269216312457214">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bruera</surname><given-names>E</given-names></name>
<name><surname>Bush</surname><given-names>SH</given-names></name>
<name><surname>Willey</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers</article-title>. <source>Cancer</source> <year>2009</year>; <volume>115</volume>(<issue>9</issue>): <fpage>2004</fpage>–<lpage>2012</lpage>.</citation>
</ref>
<ref id="bibr8-0269216312457214">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Malley</surname><given-names>G</given-names></name>
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Meagher</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>The delirium experience: a review</article-title>. <source>J Psychosom Res</source> <year>2008</year>; <volume>65</volume>(<issue>3</issue>): <fpage>223</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr9-0269216312457214">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brajtman</surname><given-names>S</given-names></name>
</person-group>. <article-title>The impact on the family of terminal restlessness and its management</article-title>. <source>Palliat Med</source> <year>2003</year>; <volume>17</volume>(<issue>5</issue>): <fpage>454</fpage>–<lpage>460</lpage>.</citation>
</ref>
<ref id="bibr10-0269216312457214">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Namba</surname><given-names>M</given-names></name>
<name><surname>Morita</surname><given-names>T</given-names></name>
<name><surname>Imura</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Terminal delirium: families’ experience</article-title>. <source>Palliat Med</source> <year>2007</year>; <volume>21</volume>(<issue>7</issue>): <fpage>587</fpage>–<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr11-0269216312457214">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morita</surname><given-names>T</given-names></name>
<name><surname>Akechi</surname><given-names>T</given-names></name>
<name><surname>Ikenaga</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Terminal delirium: recommendations from bereaved families’ experiences</article-title>. <source>J Pain Symptom Manage</source> <year>2007</year>; <volume>34</volume>(<issue>6</issue>): <fpage>579</fpage>–<lpage>589</lpage>.</citation>
</ref>
<ref id="bibr12-0269216312457214">
<label>12.</label>
<citation citation-type="book">
<collab>American Psychiatric Association</collab>. <source>DSM- IV-TR: diagnostic and statistical manual of mental disorders</source>. <edition>4th ed</edition>. text rev. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>, <year>2000</year>.</citation>
</ref>
<ref id="bibr13-0269216312457214">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Rooij</surname><given-names>SE</given-names></name>
<name><surname>Schuurmans</surname><given-names>MJ</given-names></name>
<name><surname>Van</surname><given-names>Der</given-names></name>
<name><surname>Mast</surname><given-names>RC</given-names></name><etal/>
</person-group>. <article-title>Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review</article-title>. <source>Int J Geriatr Psychiatry</source> <year>2005</year>; <volume>20</volume>(<issue>7</issue>): <fpage>609</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr14-0269216312457214">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gagnon</surname><given-names>P</given-names></name>
<name><surname>Allard</surname><given-names>P</given-names></name>
<name><surname>Gagnon</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Delirium prevention in terminal cancer: assessment of a multicomponent intervention</article-title>. <source>Psychooncology</source> <year>2012</year>; <volume>21</volume>(<issue>2</issue>): <fpage>187</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr15-0269216312457214">
<label>15.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>KC</given-names></name>
<name><surname>Lipman</surname><given-names>AG</given-names></name>
</person-group>. <article-title>Drug therapy for delirium in terminally ill adult patients</article-title>. <source>Cochrane DB Syst Rev</source> [serial on the Internet] <year>2004</year>; <issue>Issue no. 2</issue>, <ext-link ext-link-type="uri" xlink:href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004770/frame.html">http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004770/frame.html</ext-link></citation>
</ref>
<ref id="bibr16-0269216312457214">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elie</surname><given-names>D</given-names></name>
<name><surname>Gagnon</surname><given-names>P</given-names></name>
<name><surname>Gagnon</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: a literature review</article-title>. <source>Can J Psychiatry</source> <year>2010</year>; <volume>55</volume>(<issue>6</issue>): <fpage>386</fpage>–<lpage>393</lpage>.</citation>
</ref>
<ref id="bibr17-0269216312457214">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Raju</surname><given-names>B</given-names></name>
<name><surname>Conroy</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Reversibility of delirium in terminally ill patients and predictors of mortality</article-title>. <source>Palliat Med</source> <year>2008</year>; <volume>22</volume>(<issue>7</issue>): <fpage>848</fpage>–<lpage>854</lpage>.</citation>
</ref>
<ref id="bibr18-0269216312457214">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaudreau</surname><given-names>J</given-names></name>
<name><surname>Gagnon</surname><given-names>P</given-names></name>
<name><surname>Roy</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Opioid medications and longitudinal risk of delirium in hospitalized cancer patients</article-title>. <source>Cancer</source> <year>2007</year>; <volume>109</volume>(<issue>11</issue>): <fpage>2365</fpage>–<lpage>2373</lpage>.</citation>
</ref>
<ref id="bibr19-0269216312457214">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaudreau</surname><given-names>J</given-names></name>
<name><surname>Gagnon</surname><given-names>P</given-names></name>
<name><surname>Harel</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Psychoactive medications and risk of delirium in hospitalized cancer patients</article-title>. <source>J Clin Oncol</source> <year>2005</year>; <volume>23</volume>(<issue>27</issue>): <fpage>6712</fpage>–<lpage>6718</lpage>.</citation>
</ref>
<ref id="bibr20-0269216312457214">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cowan</surname><given-names>JD</given-names></name>
<name><surname>Walsh</surname><given-names>D</given-names></name>
</person-group>. <article-title>Terminal sedation in palliative medicine definition and review of the literature</article-title>. <source>Support Care Cancer</source> <year>2001</year>; <volume>9</volume>(<issue>6</issue>): <fpage>403</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr21-0269216312457214">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fainsinger</surname><given-names>RL</given-names></name>
<name><surname>De Moissac</surname><given-names>D</given-names></name>
<name><surname>Mancini</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>Sedation for delirium and other symptoms in terminally ill patients in Edmonton</article-title>. <source>J Palliat Care</source> <year>2000</year>; <volume>16</volume>(<issue>2</issue>): <fpage>5</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr22-0269216312457214">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>J</given-names></name>
<name><surname>Kite</surname><given-names>S</given-names></name>
<name><surname>Kumar</surname><given-names>M</given-names></name>
</person-group>. <article-title>The recognition and documentation of delirium in hospital palliative care inpatients</article-title>. <source>Palliat Support Care</source> <year>2010</year>; <volume>8</volume>(<issue>2</issue>): <fpage>133</fpage>–<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr23-0269216312457214">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Irwin</surname><given-names>SA</given-names></name>
<name><surname>Rao</surname><given-names>S</given-names></name>
<name><surname>Bower</surname><given-names>KA</given-names></name><etal/>
</person-group>. <article-title>Psychiatric issues in palliative care: recognition of delirium in patients enrolled in hospice care</article-title>. <source>Palliat Support Care</source> <year>2008</year>; <volume>6</volume>(<issue>2</issue>): <fpage>159</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr24-0269216312457214">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agar</surname><given-names>M</given-names></name>
<name><surname>Draper</surname><given-names>B</given-names></name>
<name><surname>Phillips</surname><given-names>PA</given-names></name><etal/>
</person-group>. <article-title>Making decisions about delirium: a qualitative comparison of decision making between nurses working in palliative care, aged care, aged care psychiatry, and oncology</article-title>. <source>Palliat Med</source> <year>2011</year>; Epub ahead of print September 9, 2011, DOI: 10.1177/0269216311419884<pub-id pub-id-type="doi">10.1177/0269216311419884</pub-id>.</citation>
</ref>
<ref id="bibr25-0269216312457214">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rao</surname><given-names>S</given-names></name>
<name><surname>Ferris</surname><given-names>FD</given-names></name>
<name><surname>Irwin</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Ease of screening for depression and delirium in patients enrolled in inpatient hospice care</article-title>. <source>J Palliat Med</source> <year>2011</year>; <volume>14</volume>(<issue>3</issue>): <fpage>275</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr26-0269216312457214">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>J</given-names></name>
<name><surname>Adcock</surname><given-names>L</given-names></name>
</person-group>. <article-title>The recognition of delirium in hospice inpatient units</article-title>. <source>Palliat Med</source> <year>2012</year>; <volume>26</volume>(<issue>3</issue>): <fpage>283</fpage>–<lpage>285</lpage>.</citation>
</ref>
<ref id="bibr27-0269216312457214">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Breitbart</surname><given-names>W</given-names></name>
<name><surname>Alici</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Agitation and delirium at the end of life: “We couldn’t manage him.”</article-title> <source>JAMA</source> <year>2008</year>; <volume>300</volume>(<issue>24</issue>): <fpage>2898</fpage>–<lpage>2910</lpage>.</citation>
</ref>
<ref id="bibr28-0269216312457214">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>RP</given-names></name>
<name><surname>Helfand</surname><given-names>M</given-names></name>
<name><surname>Woolf</surname><given-names>SH</given-names></name><etal/>
</person-group>. <article-title>for the Methods Word Group, third U.S. Preventive Services Task Force. Current methods of the U.S. preventive services task force: a review of the process</article-title>. <source>Am J Prev Med</source> <year>2001</year>; <volume>20</volume>(<issue>3S</issue>): <fpage>21</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr29-0269216312457214">
<label>29.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>JMG</given-names></name>
<name><surname>Jungner</surname><given-names>G</given-names></name>
</person-group>. <source>Principles and practice of screening for disease Geneva</source>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf">http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf</ext-link>. Public Health Papers, #34, <year>1968</year>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</citation>
</ref>
<ref id="bibr30-0269216312457214">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stroup</surname><given-names>DF</given-names></name>
<name><surname>Berlin</surname><given-names>JA</given-names></name>
<name><surname>Morton</surname><given-names>SC</given-names></name><etal/>
</person-group>. <article-title>Meta-analysis of observational studies in epidemiology—a proposal for reporting</article-title>. <source>JAMA</source> <year>2000</year>; <volume>283</volume>(<issue>15</issue>): <fpage>2008</fpage>–<lpage>2012</lpage>.</citation>
</ref>
<ref id="bibr31-0269216312457214">
<label>31.</label>
<citation citation-type="book">
<collab>American Psychiatric Association</collab> (ed.). <source>DSM-III diagnostic and statistical manual of mental disorders</source>. <edition>3rd ed.</edition> <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>, <year>1980</year>.</citation>
</ref>
<ref id="bibr32-0269216312457214">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tieman</surname><given-names>J</given-names></name>
<name><surname>Sladek</surname><given-names>R</given-names></name>
<name><surname>Currow</surname><given-names>D</given-names></name>
</person-group>, <article-title>Multiple sources: mapping the literature of palliative care</article-title>. <source>Palliat Med</source>, <year>2009</year>. <volume>23</volume>(<issue>5</issue>): <fpage>425</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr33-0269216312457214">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Von Elm</surname><given-names>E</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
<name><surname>Egger</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>PLoS Med</source> <year>2007</year>; <volume>4</volume>(<issue>10</issue>): <fpage>e296</fpage>.</citation>
</ref>
<ref id="bibr34-0269216312457214">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boyle</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Guidelines for evaluating prevalence studies</article-title>. <source>Evid Base Ment Health</source> <year>1998</year>; <volume>1</volume>(<issue>2</issue>): <fpage>37</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr35-0269216312457214">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lam</surname><given-names>PT</given-names></name>
<name><surname>Tse</surname><given-names>CY</given-names></name>
<name><surname>Lee</surname><given-names>CH</given-names></name>
</person-group>. <article-title>Delirium in a palliative care unit</article-title>. <source>Prog Palliat Care</source> <year>2003</year>; <volume>13</volume>(<issue>3</issue>): <fpage>126</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr36-0269216312457214">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Durkin</surname><given-names>I</given-names></name>
<name><surname>Kearney</surname><given-names>M</given-names></name>
<name><surname>O’Siorain</surname><given-names>L</given-names></name>
</person-group>. <article-title>Psychiatric disorder in a palliative care unit</article-title>. <source>Palliat Med</source> <year>2003</year>; <volume>17</volume>(<issue>2</issue>): <fpage>212</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr37-0269216312457214">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Minagawa</surname><given-names>H</given-names></name>
<name><surname>Uchitomi</surname><given-names>Y</given-names></name>
<name><surname>Yamawaki</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Psychiatric morbidity in terminally ill cancer patients: a prospective study</article-title>. <source>Cancer</source> <year>1996</year>; <volume>78</volume>(<issue>5</issue>): <fpage>1131</fpage>–<lpage>1137</lpage>.</citation>
</ref>
<ref id="bibr38-0269216312457214">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lawlor</surname><given-names>PG</given-names></name>
<name><surname>Nekolaichuk</surname><given-names>C</given-names></name>
<name><surname>Gagnon</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer</article-title>. <source>Cancer</source> <year>2000</year>; <volume>88</volume>(<issue>12</issue>): <fpage>2859</fpage>–<lpage>2867</lpage>.</citation>
</ref>
<ref id="bibr39-0269216312457214">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gagnon</surname><given-names>P</given-names></name>
<name><surname>Allard</surname><given-names>P</given-names></name>
<name><surname>Mâsse</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring</article-title>. <source>J Pain Symptom Manage</source> <year>2000</year>; <volume>19</volume>: <fpage>412</fpage>–<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr40-0269216312457214">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sarhill</surname><given-names>N</given-names></name>
<name><surname>Walsh</surname><given-names>D</given-names></name>
<name><surname>Nelson</surname><given-names>KA</given-names></name><etal/>
</person-group>. <article-title>Assessment of delirium in advanced cancer: the use of the Bedside Confusion Scale</article-title>. <source>Am J Hosp Palliat Care</source> <year>2001</year>; <volume>18</volume>(<issue>5</issue>): <fpage>335</fpage>–<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr41-0269216312457214">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spiller</surname><given-names>JA</given-names></name>
<name><surname>Keen</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care</article-title>. <source>Palliat Med</source> <year>2006</year>; <volume>20</volume>(<issue>1</issue>): <fpage>17</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr42-0269216312457214">
<label>42.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>, <year>1993</year>.</citation>
</ref>
<ref id="bibr43-0269216312457214">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adamis</surname><given-names>D</given-names></name>
<name><surname>Sharma</surname><given-names>N</given-names></name>
<name><surname>Whelan</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Delirium scales: a review of current evidence</article-title>. <source>Aging Ment Health</source> <year>2010</year>; <volume>14</volume>(<issue>5</issue>): <fpage>543</fpage>–<lpage>555</lpage>.</citation>
</ref>
<ref id="bibr44-0269216312457214">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>MJ</given-names></name>
<name><surname>Breitbart</surname><given-names>WS</given-names></name>
<name><surname>Platt</surname><given-names>MM</given-names></name>
</person-group>. <article-title>A critique of instruments and methods to detect, diagnose, and rate delirium</article-title>. <source>J Pain Symptom Manage</source> <year>1995</year>; <volume>10</volume>(<issue>1</issue>): <fpage>35</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr45-0269216312457214">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Delirium/acute confusional states: evaluation devices in nursing</article-title>. <source>Int Psychogeriatr</source> <year>1991</year>; <volume>3</volume>(<issue>02</issue>): <fpage>301</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr46-0269216312457214">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stillman</surname><given-names>MJ</given-names></name>
<name><surname>Rybicki</surname><given-names>LA</given-names></name>
</person-group>. <article-title>The Bedside Confusion Scale: development of a portable bedside test for confusion and its application to the palliative medicine population</article-title>. <source>J Palliat Med</source> <year>2000</year>; <volume>3</volume>(<issue>4</issue>): <fpage>449</fpage>–<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr47-0269216312457214">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folstein</surname><given-names>MF</given-names></name>
<name><surname>Folstein</surname><given-names>SE</given-names></name>
<name><surname>McHugh</surname><given-names>PR</given-names></name>
</person-group>. <article-title>“Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatr Res</source> <year>1975</year>; <volume>12</volume>: <fpage>189</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr48-0269216312457214">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katzman</surname><given-names>R</given-names></name>
<name><surname>Brown</surname><given-names>T</given-names></name>
<name><surname>Fuld</surname><given-names>P</given-names></name>
</person-group>. <article-title>Validation of a short orientation-memory-concentration test of congestive impairment</article-title>. <source>Am J Psychiatry</source> <year>1983</year>; <volume>140</volume>(<issue>6</issue>): <fpage>734</fpage>–<lpage>739</lpage>.</citation>
</ref>
<ref id="bibr49-0269216312457214">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Inouye</surname><given-names>SK</given-names></name>
<name><surname>Van Dyck</surname><given-names>CH</given-names></name>
<name><surname>Alessi</surname><given-names>CA</given-names></name><etal/>
</person-group>. <article-title>Clarifying confusion: the confusion assessment method. A new method for detection of delirium</article-title>. <source>Ann Intern Med</source> <year>1990</year>; <volume>113</volume>(<issue>12</issue>): <fpage>941</fpage>–<lpage>948</lpage>.</citation>
</ref>
<ref id="bibr50-0269216312457214">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Breitbart</surname><given-names>W</given-names></name>
<name><surname>Rosenfeld</surname><given-names>B</given-names></name>
<name><surname>Roth</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>The memorial delirium assessment scale</article-title>. <source>J Pain Symptom Manage</source> <year>1997</year>; <volume>13</volume>(<issue>3</issue>): <fpage>128</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr51-0269216312457214">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trzepacz</surname><given-names>PT</given-names></name>
<name><surname>Baker</surname><given-names>RW</given-names></name>
<name><surname>Greenhouse</surname><given-names>J</given-names></name>
</person-group>. <article-title>A symptom rating scale for delirium</article-title>. <source>Psychiatr Res</source> <year>1988</year>; <volume>23</volume>: <fpage>89</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr52-0269216312457214">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trzepacz</surname><given-names>PTR</given-names></name>
<name><surname>Kanary</surname><given-names>K</given-names></name>
<name><surname>Norton</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Validation of the Delirium Rating Scale-Revised-98: comparison with the Delirium Rating Scale and the Cognitive Test for Delirium</article-title>. <source>J Neuropsychiatry Clin Neurosci</source> <year>2001</year>; <volume>13</volume>(<issue>2</issue>): <fpage>229</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr53-0269216312457214">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grassi</surname><given-names>L</given-names></name>
<name><surname>Caraceni</surname><given-names>A</given-names></name>
<name><surname>Beltrami</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Assessing delirium in cancer patients. The Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale</article-title>. <source>J Pain Symptom Manage</source> <year>2001</year>; <volume>21</volume>(<issue>1</issue>): <fpage>59</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr54-0269216312457214">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>K</given-names></name>
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Guerin</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Validation of the confusion assessment method in the palliative care setting</article-title>. <source>Palliat Med</source> <year>2009</year>; <volume>23</volume>: <fpage>40</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr55-0269216312457214">
<label>55.</label>
<citation citation-type="book">
<collab>Clinical Epidemiology and Health Service Evaluation Unit MH</collab>. <source>Clinical practice guidelines for the management of delirium in older people</source>. <year>2006</year>. <publisher-name>“Australian Health Ministers’ Advisory Council (AHMAC)</publisher-name>: <publisher-loc>Melbourne</publisher-loc>.</citation>
</ref>
<ref id="bibr56-0269216312457214">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ely</surname><given-names>EW</given-names></name>
<name><surname>Inouye</surname><given-names>SK</given-names></name>
<name><surname>Bernard</surname><given-names>GR</given-names></name><etal/>
</person-group>. <article-title>Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)</article-title>. <source>JAMA</source> <year>2001</year>; <volume>286</volume>(<issue>21</issue>): <fpage>2703</fpage>–<lpage>2710</lpage>.</citation>
</ref>
<ref id="bibr57-0269216312457214">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ely</surname><given-names>EW</given-names></name>
<name><surname>Margolin</surname><given-names>R</given-names></name>
<name><surname>Francis</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)</article-title>. <source>Crit Care Med</source> <year>2001</year>; <volume>29</volume>(<issue>7</issue>): <fpage>1370</fpage>–<lpage>1379</lpage>.</citation>
</ref>
<ref id="bibr58-0269216312457214">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNicoll</surname><given-names>L</given-names></name>
<name><surname>Pisani</surname><given-names>MA</given-names></name>
<name><surname>Ely</surname><given-names>EW</given-names></name><etal/>
</person-group>. <article-title>Detection of delirium in the intensive care unit: comparison of confusion assessment method for the intensive care unit with confusion assessment method ratings</article-title>. <source>J Am Geriatr Soc</source> <year>2005</year>; <volume>53</volume>(<issue>3</issue>): <fpage>495</fpage>–<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr59-0269216312457214">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Galanakis</surname><given-names>P</given-names></name>
<name><surname>Bickel</surname><given-names>H</given-names></name>
<name><surname>Gradinger</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Acute confusional state in the elderly following hip surgery: incidence, risk factors and complications</article-title>. <source>Int J Geriatr Psychiatry</source> <year>2001</year>; <volume>16</volume>(<issue>4</issue>): <fpage>349</fpage>–<lpage>355</lpage>.</citation>
</ref>
<ref id="bibr60-0269216312457214">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santana Santos</surname><given-names>F</given-names></name>
<name><surname>Wahlund</surname><given-names>LO</given-names></name>
<name><surname>Varli</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Incidence, clinical features and subtypes of delirium in elderly patients treated for hip fractures</article-title>. <source>Dement Geriatr Cogn Disord</source> <year>2005</year>; <volume>20</volume>(<issue>4</issue>): <fpage>231</fpage>–<lpage>237</lpage>.</citation>
</ref>
<ref id="bibr61-0269216312457214">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCusker</surname><given-names>J</given-names></name>
<name><surname>Cole</surname><given-names>MG</given-names></name>
<name><surname>Voyer</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Prevalence and incidence of delirium in long-term care</article-title>. <source>Int J Geriatr Psychiatry</source> <year>2011</year>; <volume>26</volume>: <fpage>1152</fpage>–<lpage>1161</lpage>.</citation>
</ref>
<ref id="bibr62-0269216312457214">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Donnelly</surname><given-names>S</given-names></name>
<name><surname>Conroy</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Phenomenological and neuropsychological profile across motor variants of delirium in a palliative-care unit</article-title>. <source>J Neuropsychiatry Clin Neurosci</source> <year>2011</year>; <volume>23</volume>(<issue>2</issue>): <fpage>180</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr63-0269216312457214">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meagher</surname><given-names>DJ</given-names></name>
<name><surname>Leonard</surname><given-names>M</given-names></name>
<name><surname>Donnelly</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis</article-title>. <source>J Psychosom Res</source> <year>2011</year>; <volume>71</volume>(<issue>6</issue>): <fpage>395</fpage>–<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr64-0269216312457214">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steinhauser</surname><given-names>KE</given-names></name>
<name><surname>Christakis</surname><given-names>NA</given-names></name>
<name><surname>Clipp</surname><given-names>EC</given-names></name><etal/>
</person-group>. <article-title>Factors considered important at the end of life by patients, family, physicians, and other care providers</article-title>. <source>JAMA</source> <year>2000</year>; <volume>284</volume>(<issue>19</issue>): <fpage>2476</fpage>–<lpage>2482</lpage>.</citation>
</ref>
<ref id="bibr65-0269216312457214">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cole</surname><given-names>MG</given-names></name>
<name><surname>Dendukuri</surname><given-names>N</given-names></name>
<name><surname>McCusker</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>An empirical study of different diagnostic criteria for delirium among elderly medical inpatients</article-title>. <source>J Neuropsychiatry Clin Neurosci</source> <year>2003</year>; <volume>15</volume>(<issue>2</issue>): <fpage>200</fpage>–<lpage>207</lpage>.</citation>
</ref>
<ref id="bibr66-0269216312457214">
<label>66.</label>
<citation citation-type="book">
<collab>Canadian Coalition for Seniors’ Mental Health (CCSMH)</collab>. <source>Guideline on the assessment and treatment of delirium in older adults at the end of life</source>. <year>2010</year>. <publisher-name>Canadian Coalition for Seniors’ Mental Health ( CCSMH )</publisher-name>: <publisher-loc>Toronto</publisher-loc>.</citation>
</ref>
<ref id="bibr67-0269216312457214">
<label>67.</label>
<citation citation-type="book">
<collab>National Clinical Guideline Centre for Acute and Chronic Conditions</collab>, <article-title>Delirium: diagnosis, prevention and management, NICE Clinical Guideline 103</article-title>, <year>2010</year>, <publisher-name>National Institute for Health and Clinical Excellence</publisher-name>: <publisher-loc>London</publisher-loc>.</citation>
</ref>
<ref id="bibr68-0269216312457214">
<label>68.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Agar</surname><given-names>M</given-names></name>
</person-group>. <source>Randomised control trial of oral risperidone, oral haloperidol, and oral placebo with rescue subcutaneous midazolam in the management of delirium in palliative care inpatients</source> [Clinical Trial Protocol]. <publisher-loc>Adelaide, SA, Australia</publisher-loc>: <publisher-name>Flinders University</publisher-name>, <year>2010</year>; <ext-link ext-link-type="uri" xlink:href="http://www.caresearch.com.au/Caresearch/Portals/0/Documents/RESEARCH-RESOURCES/Research-Studies-Register/0071.pdf">http://www.caresearch.com.au/Caresearch/Portals/0/Documents/RESEARCH-RESOURCES/Research-Studies-Register/0071.pdf</ext-link></citation>
</ref>
<ref id="bibr69-0269216312457214">
<label>69.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Lonergan</surname><given-names>E</given-names></name>
<name><surname>Luxenberg</surname><given-names>J</given-names></name>
<name><surname>Areosa Sastre</surname><given-names>A</given-names></name>
</person-group>. <article-title>Benzodiazepines for delirium</article-title>. <source>Cochrane DB Syst Rev</source> [serial on the Internet] <year>2009</year>; <issue>Issue no. 4</issue>, <ext-link ext-link-type="uri" xlink:href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006379/frame.html">http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006379/frame.html</ext-link></citation>
</ref>
<ref id="bibr70-0269216312457214">
<label>70.</label>
<citation citation-type="web">
<collab>World Health Organization</collab>. <article-title>WHO Definition of Palliative Care</article-title>. <year>2002</year>; <ext-link ext-link-type="uri" xlink:href="http://www.who.int/cancer/palliative/definition/en/">http://www.who.int/cancer/palliative/definition/en/</ext-link></citation>
</ref>
<ref id="bibr71-0269216312457214">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eagar</surname><given-names>K</given-names></name>
</person-group>. <article-title>The Australian Palliative Care Outcomes Collaboration (PCOC)—measuring the quality and outcomes of palliative care on a routine basis</article-title>. <source>Aust Health Rev</source> <year>2010</year>; <volume>34</volume>(<issue>2</issue>): <fpage>186</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr72-0269216312457214">
<label>72.</label>
<citation citation-type="web">
<collab>Cicely Saunders Institute</collab>. <source>Palliative Care Outcome Scale</source>. <publisher-loc>London</publisher-loc>. <ext-link ext-link-type="uri" xlink:href="http://pos-pal.org/index.php">http://pos-pal.org/index.php</ext-link> (<access-date>accessed 29 March 2012</access-date>).</citation>
</ref>
<ref id="bibr73-0269216312457214">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>
<name><surname>Von Elm</surname><given-names>E</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name><etal/>
</person-group>. <article-title>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration</article-title> <source>PLoS Med</source> <year>2007</year>; <volume>4</volume>(<issue>10</issue>), <fpage>e297</fpage>. PMID: 17941715.</citation>
</ref>
<ref id="bibr74-0269216312457214">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leslie</surname><given-names>DL</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Bogardus</surname><given-names>ST</given-names></name><etal/>
</person-group>. <article-title>Consequences of preventing delirium in hospitalized older adults on nursing home costs</article-title>. <source>J Am Geriatr Soc</source> <year>2005</year>; <volume>53</volume>(<issue>3</issue>): <fpage>405</fpage>–<lpage>409</lpage>.</citation>
</ref>
<ref id="bibr75-0269216312457214">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leslie</surname><given-names>DL</given-names></name>
<name><surname>Marcantonio</surname><given-names>ER</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>One-year health care costs associated with delirium in the elderly population</article-title>. <source>Arch Intern Med</source> <year>2008</year>; <volume>168</volume>(<issue>1</issue>): <fpage>27</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr76-0269216312457214">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murray</surname><given-names>SK</given-names></name>
<name><surname>Kendall</surname><given-names>M</given-names></name>
<name><surname>Boyd</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Illness trajectories and palliative care</article-title>. <source>BMJ</source> <year>2005</year>; <volume>330</volume>: <fpage>1007</fpage>–<lpage>1011</lpage>.</citation>
</ref>
<ref id="bibr77-0269216312457214">
<label>77.</label>
<citation citation-type="book">
<collab>World Health Organisation</collab>. <source>Palliative care for older people: better practices</source>. <person-group person-group-type="editor">
<name><surname>Hall</surname><given-names>Sue</given-names></name>
<name><surname>Petkova</surname><given-names>Hristina</given-names></name>
<name><surname>Tsouros</surname><given-names>Agis D.</given-names></name>
<name><surname>Costantini</surname><given-names>Massimo</given-names></name>
<name><surname>Higginson</surname><given-names>Irene J</given-names></name>
</person-group>., Eds, <year>2011</year>, <publisher-name>WHO Regional Office for Europe</publisher-name>: <publisher-loc>Copenhagen</publisher-loc>.</citation>
</ref>
<ref id="bibr78-0269216312457214">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Janssen</surname><given-names>DJA</given-names></name>
<name><surname>Spruit</surname><given-names>MA</given-names></name>
<name><surname>Wouters</surname><given-names>EFM</given-names></name><etal/>
</person-group>. <article-title>Daily symptom burden in end-stage chronic organ failure: a systematic review</article-title>. <source>Palliat Med</source> <year>2008</year>; <volume>22</volume>(<issue>8</issue>): <fpage>938</fpage>–<lpage>948</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>